News

KTLA28d
GlycoNex Announces Publication of Research Involving Pro-Antibody, GNX201, in the International Journal of Biological Macromolecules - KTLA
GNX201 is an anti-TACA pro-antibody that applies PrecisemAb Biotech's proprietary "Antibody Lock" technology, by fusing a masking peptide to the variable region of the anti-TACA mAb via a ...
KXAN28d
GlycoNex Announces Publication of Research Involving Pro-Antibody, GNX201, in the International Journal of Biological Macromolecules - KXAN Austin
GNX201 is an anti-TACA pro-antibody that applies PrecisemAb Biotech's proprietary "Antibody Lock" technology, by fusing a masking peptide to the variable region of the anti-TACA mAb via a ...
WREG28d
GlycoNex Announces Publication of Research Involving Pro-Antibody, GNX201, in the International Journal of Biological Macromolecules - WREG.com
Pre-clinical research demonstrates selectivity and safety of protease-activated antibody for gastrointestinal cancers NEW TAIPEI CITY, Taiwan, May 27, 2025 /PRNewswire/ -- GlycoNex, Inc. (4168 ...
AZoNano on MSN14d
Optimizing Antigen Density on Gold Nanoparticles for Cancer Vaccines
A study in Chemistry A European Journal reveals that reduced MUC1 antigen density on gold nanoparticles still elicits potent tumor-specific immune responses, supporting flexible cancer vaccine design ...
pharmaphorum5d
Janux plans $200m offer on back of prostate cancer readout
Janux Therapeutics files $200m public offer after early-stage data for its prostate cancer T-cell engager sparks a huge rise in its share price.
WROC-TV28d
GlycoNex Announces Publication of Research Involving Pro-Antibody, GNX201, in the International Journal of Biological Macromolecules - RochesterFirst
Pre-clinical research demonstrates selectivity and safety of protease-activated antibody for gastrointestinal cancers NEW TAIPEI CITY, Taiwan, May 27, 2025 /PRNewswire/ -- GlycoNex, Inc. (4168, ...